-
Je něco špatně v tomto záznamu ?
Inhibitor of apoptosis proteins in human health and disease
M. Hrdinka, M. Yabal,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
ProQuest Central
od 2019-01-01 do Před 1 rokem
Open Access Digital Library
od 1999-01-01
Health & Medicine (ProQuest)
od 2019-01-01 do Před 1 rokem
- MeSH
- autoimunitní nemoci imunologie patologie MeSH
- buněčná smrt MeSH
- infekce imunologie patologie MeSH
- inflamasomy imunologie MeSH
- inhibitory apoptózy genetika imunologie MeSH
- lidé MeSH
- signální transdukce MeSH
- viabilita buněk * MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The inhibitor of apoptosis proteins (IAPs) are best known for their ability to regulate cell survival and death processes. However, in addition to cell death, IAPs also act as innate immune sensors and modulate multiple pathways, such as autophagy and cell division. Many of these IAP functions are non-redundant even though they are based on the same molecular mechanism of action. These distinct functions of IAPs derive from their capacity to target specific substrates for ubiquitination and/or proteolytic cleavage. The unique functions of IAPs also derives from their unique cellular localizations, cell type and tissue-specific expression patterns. The diverse roles of IAPs are reflected by the fact that in humans the IAP family comprises eight distinct members. Genetic evidence from human pathologies also attests to the non-redundant functions of the IAPs since very diverse diseases arise upon aberrant IAP expression. In this review, we give an overview of the known mechanisms of action of the various IAPs, and focus on their specific roles in mediating innate immunity. We also look at the distinct phenotypes related to the dysregulation of the IAPs, and the human pathologies associated with each human IAP.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006349
- 003
- CZ-PrNML
- 005
- 20200525102411.0
- 007
- ta
- 008
- 200511s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41435-019-0078-8 $2 doi
- 035 __
- $a (PubMed)31110240
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Hrdinka, Matous $u Department of Haematooncology, University Hospital Ostrava, 17. listopadu 1790, 70800, Ostrava, Czech Republic. Faculty of Medicine, University of Ostrava, Syllabova 19, 70300, Ostrava, Czech Republic.
- 245 10
- $a Inhibitor of apoptosis proteins in human health and disease / $c M. Hrdinka, M. Yabal,
- 520 9_
- $a The inhibitor of apoptosis proteins (IAPs) are best known for their ability to regulate cell survival and death processes. However, in addition to cell death, IAPs also act as innate immune sensors and modulate multiple pathways, such as autophagy and cell division. Many of these IAP functions are non-redundant even though they are based on the same molecular mechanism of action. These distinct functions of IAPs derive from their capacity to target specific substrates for ubiquitination and/or proteolytic cleavage. The unique functions of IAPs also derives from their unique cellular localizations, cell type and tissue-specific expression patterns. The diverse roles of IAPs are reflected by the fact that in humans the IAP family comprises eight distinct members. Genetic evidence from human pathologies also attests to the non-redundant functions of the IAPs since very diverse diseases arise upon aberrant IAP expression. In this review, we give an overview of the known mechanisms of action of the various IAPs, and focus on their specific roles in mediating innate immunity. We also look at the distinct phenotypes related to the dysregulation of the IAPs, and the human pathologies associated with each human IAP.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a autoimunitní nemoci $x imunologie $x patologie $7 D001327
- 650 _2
- $a buněčná smrt $7 D016923
- 650 12
- $a viabilita buněk $7 D002470
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a infekce $x imunologie $x patologie $7 D007239
- 650 _2
- $a inflamasomy $x imunologie $7 D058847
- 650 _2
- $a inhibitory apoptózy $x genetika $x imunologie $7 D051034
- 650 _2
- $a signální transdukce $7 D015398
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Yabal, Monica $u Institute of Molecular Immunology and Experimental Oncology, School of Medicine, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany. monica.yabal@tum.de.
- 773 0_
- $w MED00007954 $t Genes and immunity $x 1476-5470 $g Roč. 20, č. 8 (2019), s. 641-650
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31110240 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200525102411 $b ABA008
- 999 __
- $a ok $b bmc $g 1525207 $s 1096405
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 20 $c 8 $d 641-650 $e 20190521 $i 1476-5470 $m Genes and immunity $n Genes Immun $x MED00007954
- LZP __
- $a Pubmed-20200511